Unknown

Dataset Information

0

Amyloid ?-Protein C-Terminal Fragments: Formation of Cylindrins and ?-Barrels.


ABSTRACT: In order to evaluate potential therapeutic targets for treatment of amyloidoses such as Alzheimer's disease (AD), it is essential to determine the structures of toxic amyloid oligomers. However, for the amyloid ?-protein peptide (A?), thought to be the seminal neuropathogenetic agent in AD, its fast aggregation kinetics and the rapid equilibrium dynamics among oligomers of different size pose significant experimental challenges. Here we use ion-mobility mass spectrometry, in combination with electron microscopy, atomic force microscopy, and computational modeling, to test the hypothesis that A? peptides can form oligomeric structures resembling cylindrins and ?-barrels. These structures are hypothesized to cause neuronal injury and death through perturbation of plasma membrane integrity. We show that hexamers of C-terminal A? fragments, including A?(24-34), A?(25-35) and A?(26-36), have collision cross sections similar to those of cylindrins. We also show that linking two identical fragments head-to-tail using diglycine increases the proportion of cylindrin-sized oligomers. In addition, we find that larger oligomers of these fragments may adopt ?-barrel structures and that ?-barrels can be formed by folding an out-of-register ?-sheet, a common type of structure found in amyloid proteins.

SUBMITTER: Do TD 

PROVIDER: S-EPMC4741107 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Amyloid β-Protein C-Terminal Fragments: Formation of Cylindrins and β-Barrels.

Do Thanh D TD   LaPointe Nichole E NE   Nelson Rebecca R   Krotee Pascal P   Hayden Eric Y EY   Ulrich Brittany B   Quan Sarah S   Feinstein Stuart C SC   Teplow David B DB   Eisenberg David D   Shea Joan-Emma JE   Bowers Michael T MT  

Journal of the American Chemical Society 20160106 2


In order to evaluate potential therapeutic targets for treatment of amyloidoses such as Alzheimer's disease (AD), it is essential to determine the structures of toxic amyloid oligomers. However, for the amyloid β-protein peptide (Aβ), thought to be the seminal neuropathogenetic agent in AD, its fast aggregation kinetics and the rapid equilibrium dynamics among oligomers of different size pose significant experimental challenges. Here we use ion-mobility mass spectrometry, in combination with ele  ...[more]

Similar Datasets

| S-EPMC7496786 | biostudies-literature
| S-EPMC3149364 | biostudies-literature
| S-EPMC6032360 | biostudies-literature
| S-EPMC8081394 | biostudies-literature
| S-EPMC3929097 | biostudies-literature
| S-EPMC4777659 | biostudies-literature
| S-EPMC3366005 | biostudies-literature
| S-EPMC5057504 | biostudies-literature
| S-EPMC5361499 | biostudies-literature
| S-EPMC9247468 | biostudies-literature